Literature DB >> 22237956

Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.

Yong-sheng Yu1, Zheng-hao Tang, Qing-chun Pan, Xiao-hua Chen, Xue-ni Liu, Guo-qing Zang.   

Abstract

PURPOSE: Csn3 (or CSN3) encodes the third subunit of an eight-subunit complex, the COP9 signalosome (CSN), which acts as a protein kinase and a deneddylase in mammalian cells. Previous studies have shown that Csn3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast and associated with the tumorigenesis process in osteosarcoma. However, its correlation with hepatocellular carcinoma (HCC) has not been explored yet.
METHODS: The expression of Csn3 in HCC (n = 30), cirrhosis (n = 30), and normal tissues (n = 30) was detected using immunohistochemical analysis. The impacts of lentivirus-mediated inhibition of Csn3 on HCC cells were detected using MTT, BrdU incorporation assay, and flow cytometric analysis. In addition, the colony formation and tumor growth ability in nude mice were detected to define the role of Csn3 in tumorigenesis.
RESULTS: Knockdown of Csn3 expression in HCC cell lines (SMMC-7721 and Hep3B) significantly inhibits the tumor growth both in vitro and in vivo. Further investigation indicates that this growth inhibition effect may be mediated through cell cycle arrest in G0/G1 phase and inductions of pro-apoptotic proteins BIK and Caspase-8. In addition, knockdown of Csn3 expression evidently suppresses tumor growth in a xenograft nude mice model.
CONCLUSION: Collectively, this study demonstrates Csn3 as an oncogene that regulates the tumorigenesis process in HCC cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237956     DOI: 10.1007/s00280-011-1810-x

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

Review 1.  Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.

Authors:  Yunbao Pan; Huiling Yang; Francois X Claret
Journal:  Cancer Biol Ther       Date:  2014-02-04       Impact factor: 4.742

2.  Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway.

Authors:  Mariam A Ba; Jeffrey Surina; Cherie A Singer; Maria L Valencik
Journal:  BMC Pharmacol Toxicol       Date:  2017-06-17       Impact factor: 2.483

3.  Knockdown of COPS3 Inhibits Lung Cancer Tumor Growth in Nude Mice by Blocking Cell Cycle Progression.

Authors:  Jianan Pang; Xu Yan; He Cao; Lei Qian; Hua He; Huimin Tian; Fujun Han; Guanjun Wang; Xiao Chen; Yuguang Zhao; Ji-Fan Hu; Jiuwei Cui
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

4.  Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.

Authors:  Fan Zhang; Taiqiang Yan; Wei Guo; Kunkun Sun; Shidong Wang; Xing Bao; Kuisheng Liu; Bingxin Zheng; Hongliang Zhang; Tingting Ren
Journal:  J Exp Clin Cancer Res       Date:  2018-07-03

5.  CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.

Authors:  Jie Mou; Lulu Wei; Jia Liang; Wenqi Du; Dongsheng Pei
Journal:  Int J Med Sci       Date:  2020-10-01       Impact factor: 3.738

6.  Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.

Authors:  Xiaoqing Yu; Jingsong Zhang; Rui Yang; Chun Li
Journal:  Biomed Res Int       Date:  2020-11-14       Impact factor: 3.411

7.  Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.

Authors:  Di Meng; Tongjun Liu; Feng Ma; Mingguo Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 8.  Targeting the COP9 signalosome for cancer therapy.

Authors:  Wenqi Du; Ruicheng Zhang; Bilal Muhammad; Dongsheng Pei
Journal:  Cancer Biol Med       Date:  2022-03-21       Impact factor: 5.347

9.  Inhibition of neddylation induces mitotic defects and alters MKLP1 accumulation at the midbody during cytokinesis.

Authors:  Dudley Chung; Jayme Salsman; Graham Dellaire
Journal:  Cell Cycle       Date:  2019-05-05       Impact factor: 4.534

10.  CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression.

Authors:  Hangwei Fu; Yida Zhang; Yin Chen; Junying Chen; Ping Chen
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.